Back to Search Start Over

Pathophysiology of chikungunya virus infection associated with fatal outcomes.

Authors :
de Souza WM
Fumagalli MJ
de Lima STS
Parise PL
Carvalho DCM
Hernandez C
de Jesus R
Delafiori J
Candido DS
Carregari VC
Muraro SP
Souza GF
Simões Mello LM
Claro IM
Díaz Y
Kato RB
Trentin LN
Costa CHS
Maximo ACBM
Cavalcante KF
Fiuza TS
Viana VAF
Melo MEL
Ferraz CPM
Silva DB
Duarte LMF
Barbosa PP
Amorim MR
Judice CC
Toledo-Teixeira DA
Ramundo MS
Aguilar PV
Araújo ELL
Costa FTM
Cerqueira-Silva T
Khouri R
Boaventura VS
Figueiredo LTM
Fang R
Moreno B
López-Vergès S
Mello LP
Skaf MS
Catharino RR
Granja F
Martins-de-Souza D
Plante JA
Plante KS
Sabino EC
Diamond MS
Eugenin E
Proença-Módena JL
Faria NR
Weaver SC
Source :
Cell host & microbe [Cell Host Microbe] 2024 Apr 10; Vol. 32 (4), pp. 606-622.e8. Date of Electronic Publication: 2024 Mar 12.
Publication Year :
2024

Abstract

Chikungunya virus (CHIKV) is a mosquito-borne alphavirus that causes acute, subacute, and chronic human arthritogenic diseases and, in rare instances, can lead to neurological complications and death. Here, we combined epidemiological, virological, histopathological, cytokine, molecular dynamics, metabolomic, proteomic, and genomic analyses to investigate viral and host factors that contribute to chikungunya-associated (CHIK) death. Our results indicate that CHIK deaths are associated with multi-organ infection, central nervous system damage, and elevated serum levels of pro-inflammatory cytokines and chemokines compared with survivors. The histopathologic, metabolite, and proteomic signatures of CHIK deaths reveal hemodynamic disorders and dysregulated immune responses. The CHIKV East-Central-South-African lineage infecting our study population causes both fatal and survival cases. Additionally, CHIKV infection impairs the integrity of the blood-brain barrier, as evidenced by an increase in permeability and altered tight junction protein expression. Overall, our findings improve the understanding of CHIK pathophysiology and the causes of fatal infections.<br />Competing Interests: Declaration of interests M.S.D. is a consultant or advisor for Inbios, Ocugen, Vir Biotechnology, Topspin Therapeutics, Moderna, Merck, and Immunome. The Diamond laboratory has received funding support from Emergent BioSolutions, Moderna, and Vir Biotechnology.<br /> (Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved.)

Details

Language :
English
ISSN :
1934-6069
Volume :
32
Issue :
4
Database :
MEDLINE
Journal :
Cell host & microbe
Publication Type :
Academic Journal
Accession number :
38479396
Full Text :
https://doi.org/10.1016/j.chom.2024.02.011